Cross-neutralization of antibodies induced by vaccination with Puri fied Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 10, 2014, Pages 2799-2804

  Malerczyk, Claudius ^a   Freuling, Conrad ^b   Gniel, Dieter ^a   Giesen, Alexandra ^a   Selhorst, Thomas ^b   Müller, Thomas ^b  

^a Novartis Vaccine   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Cross neutralization; Lyssavirus; PCECV; Rabies; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; BOKELOH BAT LYSSAVIRUS; CONTROLLED STUDY; CROSS REACTION; DUVENHAGE VIRUS; ETHIOPIA; EUROPEAN BAT LYSSAVIRUS 1; EUROPEAN BAT LYSSAVIRUS 2; HUMAN; LAGOS BAT VIRUS; LYSSAVIRUS; MOKOLA VIRUS; NIGERIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; RABIES VIRUS; VACCINATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; ANIMAL; CHICK EMBRYO; CLASSIFICATION; CROSS PROTECTION; DOG; IMMUNOLOGY; RABIES;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHICK EMBRYO; CROSS PROTECTION; DOGS; HUMANS; LYSSAVIRUS; RABIES; RABIES VACCINES; VACCINATION;

EID: 84921305467     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/21645515.2014.972741     Document Type: Article

References (36)

1. WHO. World Health Organization Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013:1-139.
2. WHO. Rabies Vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 32(85):309-20.
3. Freuling CM, Hampson K, Selhorst T, Schröder R, Meslin FX, Mettenleiter TC, Müller T. The elimination of fox rabies from Europe: determinants of success and lessons for the future. Philos Trans R Soc Lond B Biol Sci 2013; 368 (1623):20120142; PMID:23798690; http://dx.doi.org/10.1098/rstb.2012.0142
4. Hanlon CA, Childs JE. Epidemiology. In: Jackson AC, ed. Rabies, 3rd Edition. Oxford: Academic Press; 2013; 61-121.
5. Kuzmina NA, Kuzmin IV, Ellison JA, Taylor ST, Bergman DL, Dew B, Rupprecht CE. A reassessment of the evolutionary timescale of bat rabies viruses based upon glycoprotein gene sequences. Virus Genes 2013; 47 (2):305-10; PMID:23839669; http://dx.doi.org/10.1007/s11262-013-0952-9
6. Rupprecht CE, Turmelle A, Kuzmin IV. A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol 2011; 1(6):662-70; PMID:22440925; http://dx.doi.org/10.1016/j.coviro.2011.10.014
7. Schatz J, Fooks R, McElhinney L, Horton D, Echevarria J, Vazquez-Moron S, Kooi EA, Rasmussen TB, Müller T, Freuling CM. Bat Rabies Surveillance in Europe. Zoonoses Public Health 2013; 60(1):22-34; PMID:22963584; http://dx.doi.org/10.1111/zph.12002
8. Freuling C, Beer M, Conraths FJ, Finke S, Hoffmann B, Keller B, Kliemt J, Mettenleiter TC, Mühlbach E, Teifke JP, et al. Novel Lyssavirus in Natterer's Bat, Germany. Emerg Infect Dis 2011; 17(8):1519-22; PMID:21801640
9. Freuling CM, Abendroth B, Beer M, Fischer M, Hanke D, Hoffmann B, Höper D, Just F, Mettenleiter TC, Schatz J, et al. Molecular diagnostics for the detection of Bokeloh bat lyssavirus in a bat from Bavaria, Germany. Virus Res 2013; 177(2):201-4; PMID:23932899; http://dx.doi.org/10.1016/j.virusres.2013.07.021
10. Picard-Meyer E, Servat A, Robardet E, Moinet M, Borel C, Cliquet F. Isolation of Bokeloh bat lyssavirus in Myotis nattereri in France. Arch Virol 2013; 158 (11):2333-40; PMID:23760600; http://dx.doi.org/10.1007/s00705-013-1747-y
11. Marston DA1, Horton DL, Ngeleja C, Hampson K, McElhinney LM, Banyard AC, Haydon D, Cleaveland S, Rupprecht CE, Bigambo M, et al. Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet. Emerg Infect Dis 2012; 18(4):664-7; PMID:22469151; http://dx.doi.org/10.3201/eid1804.111553
12. Aréchiga Ceballos N, Vázquez Morón S, Berciano JM, Nicolás O, Aznar López C, Juste J, Rodríguez Nevado C, Aguilar Setién A, Echevarría JE. Novel lyssavirus in bat, Spain. Emerg Infect Dis 2013; 19(5):793-5; http://dx.doi.org/10.3201/eid1905.121071
13. Kgaladi J, Wright N, Coertse J, Markotter W, Marston D, Fooks AR, Freuling CM, Müller TF, Sabeta CT, Nel LH. Diversity and epidemiology of Mokola virus. PLoS Negl Trop Dis 2013; 7(10):e2511; PMID:24205423; http://dx.doi.org/10.1371/journal.pntd.0002511
14. Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC. Current status of rabies and prospects for elimination. Lancet 2014; 10.1016/S0140-6736(13)62707-5 [epub ahead of print]
15. Fooks AR, Brookes SM, Johnson N, McElhinney LM, Hutson AM. European bat lyssaviruses: an emerging zoonosis. Epidemiol Infect 2003; 131(3):1029-39; PMID:14959767; http://dx.doi.org/10.1017/S0950268803001481
16. Hanna JN, Carney IK, Smith GA, Tannenberg AE, Deverill JE, Botha JA, et al. Australian bat lyssavirus infection: a second human case, with a long incubation period. Med J Aust 2000; 172(12):597-9; PMID:10914106
17. van Thiel P-PAM, de Bie RM, Eftimov F, Tepaske R, Zaaijer HL, et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis 2009; 3:e428; PMID:19636367; http://dx.doi.org/10.1371/journal.pntd.0000428
18. Leonova GN, Belikov S, Kondratov IG, Krylova NV, Pavlenko EV, Romanova EV, Chentsova IV, Petukhova SA. A fatal case of bat lyssavirus infection in Primorye Territory of the Russian Far East. Rabies Bull Europe 2009; 33(4):5-8
19. Familusi JB, Osunkoya BO, Moore DL, Kemp GE, Fabiyi A. A fatal human infection with Mokola virus. Am J Trop Med Hyg 1972; 21(6):959-63; PMID:4635777
20. Johnson N, Vos A, Freuling C, et al. Human rabies due to lyssavirus infection of bat origin. Vet Microbiol 2010; 142:151-159; PMID:20188498; http://dx.doi.org/10.1016/j.vetmic.2010.02.001
21. Horton DL, McElhinney LM, Marston DA, Wood JL, Russell CA, Lewis N, Kuzmin IV, Fouchier RA, Osterhaus AD, Fooks AR, et al. Quantifying antigenic relationships among the lyssaviruses. J Virol 2010;84(22):11841-8; PMID:20826698; http://dx.doi.org/10.1128/JVI.01153-10
22. Weyer J, Kuzmin IV, Rupprecht CE, Nel LH. Crossprotective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes. Epidemiol Infect 2008;136 (5):670-8; PMID:17588277; http://dx.doi.org/10.1017/S0950268807008965
23. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssavirusses. Vaccine 2005; 23(32):4101-9; PMID:15964478; http://dx.doi.org/10.1016/j.vaccine.2005.03.037
24. Brookes SM, Healy DM, Fooks AR. Ability of rabies vaccine strains to elicit crossneutralising antibodies. Dev Biol (Basel) 2006; 125:185-93; PMID:16878476
25. Malerczyk C, Selhorst T, Tordo N, Moore S, Müller T. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains. Vaccine 2009; 27:5320-5; PMID:19615958; http://dx.doi.org/10.1016/j.vaccine.2009.06.095
26. Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res 2005; 111(1):44-54; PMID:15896401; http://dx.doi.org/10.1016/j.virusres.2005.03.009
27. Liu Y, Chen Q, Zhang F, Zhang S, Li N, Lian H, Wang Y, Zhang J, Hu R. Evaluation of rabies biologics against Irkut virus isolated in China. J Clin Microbiol 2013; 51(11):3499-504; PMID:23946522; http://dx.doi.org/10.1128/JCM.01565-13
28. Badrane H, Bahloul C, Perrin P, Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 2001; 75(7):3268-76; PMID:11238853; http://dx.doi.org/10.1128/JVI.75.7.3268-3276.2001
29. Mebatsion T, Cox JH, Frost JW. Isolation and characterization of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: identification of 2 isolates as Mokola and Lagos bat viruses. J Infect Dis 1992; 166(5):972-7; PMID:1402044; http://dx.doi.org/10.1093/infdis/166.5.972
30. Mebatsion T, Cox JH, Conzelmann KK. Molecular analysis of rabies-related viruses from Ethiopia. Onderstepoort J Vet Res 1993; 60(4):289-94; PMID:7777313
31. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine. 2006; 24(19):4116-21; PMID:16545510; http://dx.doi.org/10.1016/j.vaccine.2006.02.036
32. Vos A, Müller T, Neubert L, Zurbriggen A, Botteron C, Pöhle D, Schoon H, Haas L, Jackson AC. Rabies in Red Foxes (Vulpes vulpes) Experimentally Infected with European Bat Lyssavirus Type 1. J Vet Med Ser B 2004; 51(7):327-32; http://dx.doi.org/10.1111/j.1439-0450.2004.00793.x
33. Cox JH, Schneider LG. Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. J Clin Microbiol 1976;3(2):96-101
34. Müller T, Selhorst T, Burow J, Schameitat A, Vos A. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European bat lyssavirus type 1 and 2. Dev Biol (Basel) 2006; 125:195-204; PMID:16878477
35. A Language and Environment for Statistical Computing (Version 2.14.0.) R Foundation for Statistical Computing, Vienna, Austria; 2011; ISBN 3-900051-07-0, URL: http://www.R-project.org/.
36. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 2011; 28(10):2731-9; PMID:21546353; http://dx.doi.org/10.1093/molbev/msr121